Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Production of a novel monoclonal antibody against MUC4 mucin.
Botti C, Seregni E, Menard S, Tagliabue E, Bonanate A, Cantarella D, Lombardo C, Massaron S, Martinetti A, Ferrari L, Ghirelli C, Aiello P, Bombardieri E. Botti C, et al. Among authors: martinetti a. Int J Biol Markers. 1997 Jan-Mar;12(1):42-3. Int J Biol Markers. 1997. PMID: 9176717 No abstract available.
Mucinous markers in breast cancer.
Seregni E, Botti C, Massaron S, Martinetti A, Ferrari L, Molteni SN, Bombardieri E. Seregni E, et al. Among authors: martinetti a. Tumori. 1997 Mar-Apr;83(2):550-1. doi: 10.1177/030089169708300214. Tumori. 1997. PMID: 9226018 Review. No abstract available.
The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
Bajetta E, Zilembo N, Noberasco C, Martinetti A, Mariani L, Ferrari L, Buzzoni R, Greco M, Bartoli C, Spagnoli I, Danesini GM, Artale S, Paolini J. Bajetta E, et al. Among authors: martinetti a. Eur J Cancer. 1997 Apr;33(4):587-91. doi: 10.1016/s0959-8049(96)00494-7. Eur J Cancer. 1997. PMID: 9274439 Clinical Trial.
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
Bajetta E, Zilembo N, Barni S, Noberasco C, Martinetti A, Ferrari L, Schieppati G, Buzzoni R, Jirillo A, Amichetti M, D'Aprile M, Comella G, Bichisao E, Bolelli GF, Attili A, Bombardieri E. Bajetta E, et al. Among authors: martinetti a. Ann Oncol. 1997 Jul;8(7):649-54. doi: 10.1023/a:1008270131789. Ann Oncol. 1997. PMID: 9296217 Free article. Clinical Trial.
Cost-effectiveness of tumor marker detection in cancer patients.
Bombardieri E, Massaron S, Martinetti A, Seregni E. Bombardieri E, et al. Among authors: martinetti a. Int J Biol Markers. 1997 Apr-Jun;12(2):47-8. doi: 10.1177/172460089701200201. Int J Biol Markers. 1997. PMID: 9342631 No abstract available.
124 results